(For treatment side effects and complications only)
Job Title: Consultant Haematologist & Programme Director of Stem Cell Transplantation and Cellular Therapy Unit. Honorary Senior Lecturer, University of Liverpool.
Qualifications: BSc, MB BS, DIC, PhD. MRCP(UK), MRCS (Eng), MAcadMEd, FFICM, FRCPath.
Speciality: Haemato-Oncology and intensive care medicine.
Membership/Appointments: Designated Individual, Human Tissue Authority, Stem Cell
Laboratory, Liverpool Clinical Laboratories (LCL) at RLUH; Principal
Investigator, European Blood and Marrow Transplantation (EBMT); Lead Clinician,
Haemato-Oncology clinical trials, NIHR NWC CRN; Chair, Haematology Clinic
Quality Group (CQG), Cheshire and Merseyside Cancer Alliance; Elected
President, Royal Society of Medicine, London; Chair, Stem Cell Transplantation
and Cellular Therapy SRG at CCC; Chair, Leukaemia SRG at CCC.
Clinics: The Clatterbridge Cancer Centre at The Royal Liverpool Hospital.
Tumour site(s): Acute leukaemia (acute myeloid leukaemia (AML), acute
lymphoblastic leukaemia (ALL)), Chronic myeloid leukaemia (CML), pre-acute
leukaemic diseases (including myelodysplastic syndromes (MDS), chronic myelomonocytic
leukaemia (CMML)), non-cancer blood disorders (including myeloid disorders like
aplastic anaemia, bone marrow failure syndromes, and haemophagocytic
Dr Patel graduated in Medicine from Imperial College London, where he was also awarded a PhD in Clinical Science and Molecular Genetics, after developing gene editing expertise.
He is the first NHS Consultant in the UK qualified in stem cell transplantation/cellular therapy and intensive care medicine, after completing a combined bespoke clinical and NIHR academic training programme in London based mainly at the Royal Marsden and Hammersmith Hospitals, associated with Imperial College London and The Institute of Cancer Research (University of London).
Since becoming Programme Director of The Clatterbridge Cancer Centre’s Stem Cell Transplantation and Cellular Therapy Unit, Dr Patel has achieved improved patient survival outcomes that are now amongst the best in the UK.
Dr Patel is the Lead Clinician for the Leukaemia Unit, where he has improved patient outcomes and access to innovative and emerging treatments, including through clinical trials and other early access schemes.
He is the Lead Clinician for Haemato-Oncology Clinical Trials both for the NHS Trust and the wider region of the North West Coast (NWC) National Institute for Health Research (NIHR) Clinical Research Network (CRN). Dr Patel is the UK Chief Investigator (CI) for over 10 national and international clinical trials. He is also the principal investigator (PI) for over 10 further clinical trials including autologous and allogeneic chimeric antigen receptor T cell (CAR-T) therapy studies. Some of these studies are NIHR portfolio adopted and part of the National Cancer Research Institute (NCRI) Clinical Research Group (CRG) portfolio maps.